GlobeNewswire Inc | Nov 22, 2021 07:00AM EST

November 22, 2021

MENLO PARK, Calif. and SINGAPORE, Nov. 22, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that Dr Carl Firth, CEO, will be participating in fireside chats at two upcoming virtual health conferences. The details are as follows:

Piper Sandler 33rd Annual Virtual Healthcare Conference

-- Recorded discussion available: November 22, 2021, at 10:00 am ET

4th Annual Evercore ISI HealthCONx Conference

-- Date and time: Thursday, December 2, 2021, at 8:50 am ET -- Location: Track 3

Both discussions will be accessible afterwards within the News & Events section of ASLANs Investor Relations website at https://ir.aslanpharma.com/.

Media and IR contacts

Emma Thompson Ashley R. RobinsonSpurwing Communications LifeSci Advisors, LLCTel: +65 6206 7350 Tel: +1 (617) 430-7577Email: ASLAN@spurwingcomms.com Email: arr@lifesciadvisors.com

About ASLAN PharmaceuticalsASLAN Pharmaceuticals (Nasdaq: ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLANis currently evaluatingASLAN004, apotential first-in-classantibodytargeting the IL-13 receptor,in atopic dermatitis, and ASLAN003,apotent oralinhibitorofDHODH, which is being developed forautoimmune disease.ASLAN has a team in Menlo Park, California, and in Singapore.For additional information please visitwww.aslanpharma.comor followASLANon LinkedIn.